Philip Morris International (PM) has faced varying market performance. Despite underperforming on some trading days, it surprisingly shot up in others, outperforming its competitors and delighting institutional investors who own 80% of its shares. PM’s
Intrinsic Value is currently undervalued, posing an opportunity for investors. PM's IQOS, a smoke-free product, marked its decade's journey with a $10B revenue milestone. An increase in smoke-free products is driving record revenues for
PM, with financial advisors and capital firms increasing their stake, suggesting strong market belief in PM's future performance. PM’s positive performance is poised to continue next year due to the firm’s strategic position in smoke-free product market dominance. The third-quarter and first nine-months results exceeded expectations, prompting PM to raise the guidance for its adjusted diluted EPS. PM's U.S. affiliate is expected to invest $600 million in a manufacturing facility, creating 500 jobs, while their smoke-free product, IQOS, enjoyed a 50.6% surge in nicotine pouch sales. Despite this success, insiders sold US$42m of shares, suggesting uncertainty. The third-quarter earnings beat expectations, and investment from billionaires suggest confidence in PM’s growth. However, PM is currently trading down 4.65%, yet maintaining its dividend strength.
Philip Morris International PM News Analytics from Fri, 07 Jun 2024 07:00:00 GMT to Sat, 30 Nov 2024 13:46:25 GMT -
Rating 1
- Innovation 5
- Information 7
- Rumor 3
